“Enrichment” Of Subjects In Clinical Trials Is Critical

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The planning of clinical trials to test new drugs for safety and effectiveness is no picnic under the best of circumstances. It requires a grasp of medicine, pharmacology and statistics, among other disciplines. However, when the disease or syndrome for which the drug is intended is not well circumscribed but is instead a spectrum of entities, it can be far more difficult. That makes the concept of “enrichment” critical.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC